Search

Your search keyword '"Pascoe S"' showing total 341 results

Search Constraints

Start Over You searched for: Author "Pascoe S" Remove constraint Author: "Pascoe S"
341 results on '"Pascoe S"'

Search Results

1. Blood eosinophils: a biomarker of COPD exacerbation reduction with inhaled corticosteroids

2. Bronchodilator reversibility in patients with COPD revisited: short-term reproducibility

5. Use of catch and effort data to monitor trends in economic performance in fisheries.

7. Paying attention to pigs: negotiating equity and equality in global environmental governance in Suau, Papua New Guinea

8. Leveraging routine data in impact evaluation: Understanding data systems in primary healthcare prior to a matched cluster-randomised evaluation of adherence guidelines in South Africa

12. The NERC DataGrid Services

16. Fast and friendly is key to keeping men on HIV treatment! Results from a discrete choice experiment to understand men's preferences in Johannesburg, South Africa for HIV treatment services

19. Storytelling climate change-Causality and temporality in the REDD plus regime in Papua New Guinea

21. Effectiveness of harvest strategies in achieving multiple management objectives in a multispecies fishery

27. Analysing the effect of technical change on individual outputs using modified quasi-Malmquist indexes

29. Captain Study: Simultaneous Step-Up to High Dose Fluticasone Furoate and Addition of Umeclidinium for the Treatment of Inadequately Controlled Asthma

35. Developing harvest strategies to achieve ecological, economic and social sustainability in multi-sector fisheries

36. Preventing Clinically Important Deterioration (CID) of COPD with Single-inhaler Triple Therapy Fluticasone Furoate/Umeclidinium/Vilanterol:A Prospective Analysis of the IMPACT Trial

37. InforMing the PAthway of COPD Treatment (The IMPACT Study):Single Inhaler Triple Therapy (Fluticasone Furoate/Umeclidinium/Vilanterol) Versus Fluticasone Furoate/Vilanterol and Umeclidinium/Vilanterol in Patients With COPD: An Analysis Based on Baseline COPD Medication Use

38. The IMPACT Trial:Single Inhaler Triple Therapy Fluticasone Furoate/Umeclidinium/Vilanterol Versus Fluticasone Furoate/Vilanterol and Umeclidinium/Vilanterol in Patients with COPD. Results on Cardiovascular Safety

41. The IMPACT Trial: Single Inhaler Triple Therapy Fluticasone Furoate/Umeclidinium/Vilanterol versus Fluticasone Furoate/Vilanterol and Umeclidinium/Vilanterol in Patients with COPD: A Pre-Specified Analysis of Safety According to Age

44. The IMPACT Trial: Single Inhaler Triple Therapy Fluticasone Furoate/Umeclidinium/Vilanterol Versus Fluticasone Furoate/Vilanterol and Umeclidinium/Vilanterol in Patients with COPD: Results on Cardiovascular Safety

45. The IMPACT Trial: Single Inhaler Triple Therapy fluticasone Furoate/Umeclidinium/Vilanterol Versus Fluticasone Furoate/Vilanterol and Umeclidinium/Vilanterol in Patients with COPD: Analysis According to Smoking Status

47. Blood eosinophil counts and treatment response in COPD: analyses of IMPACT

48. InforMing the PAthway of COPD Treatment (étude IMPACT) – Triple thérapie en un inhalateur unique (FF/UMEC/VI) comparée à FF/VI et UMEC/VI chez les patients atteints de BPCO : résultats basés sur une analyse de la région Europe de l’Ouest (Australie, Belgique, République Tchèque, Danemark, Finlande, France, Allemagne, Pays-Bas, Norvège, Pologne, Roumanie, Espagne, Suisse, Royaume-Uni)

49. Lifting our Game: Report of the review to achieve educational excellence in Australian schools through early childhood interventions

50. Socioeconomic Impacts of Changes to Marine Fisheries and Aquaculture that are Brought about through Climate Change

Catalog

Books, media, physical & digital resources